These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Switching drugs for lipodystophy. Fornataro K Body Posit; 1999 May; 12(5):13. PubMed ID: 11366306 [TBL] [Abstract][Full Text] [Related]
4. [Switch strategy: replacing the protease inhibitor. Quality of life improves]. MMW Fortschr Med; 2000; 142(3 Suppl):37. PubMed ID: 11012292 [No Abstract] [Full Text] [Related]
5. On the trail of fugitive fat: the chase turns to NRTIs. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871 [TBL] [Abstract][Full Text] [Related]
12. Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome. Borderi M; Verucchi G; Tadolini M; Spinosa S; Fortunato L; Talò S; Chiodo F New Microbiol; 2001 Jul; 24(3):303-15. PubMed ID: 11497090 [TBL] [Abstract][Full Text] [Related]
13. Are changes in body shape due to drug side effects? TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790 [TBL] [Abstract][Full Text] [Related]
14. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up. Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868 [TBL] [Abstract][Full Text] [Related]
18. [Facial lipodystrophy in patients with HIV infections troublesome to treat]. Walther RA Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531 [TBL] [Abstract][Full Text] [Related]
19. The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients. Milinkovic A; Martinez E; López S; de Lazzari E; Miró O; Vidal S; Blanco JL; Garrabou G; Laguno M; Arnaiz JA; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM Antivir Ther; 2007; 12(3):407-15. PubMed ID: 17591031 [TBL] [Abstract][Full Text] [Related]